SCHEMBL4841785

SCHEMBL4841785

O=C(O)c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(F)cc3Cl)cc2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
TRPA1 O75762 8/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
PTGER3 P43115 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
RORC P51449 1/20 0.34
POLB P06746 1/20 0.34
MMP3 P08254 2/20 0.34
MMP8 P22894 2/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PRKAB2 O43741 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837224 0.94 HCRTR1 (0.37) TRPA1PTGER3HCRTR1HCRTR2RORC
SCHEMBL4842704 0.93 GNRHR (0.36) MAPTTRPA1PSEN1PSEN2APH1B
SCHEMBL4837482 0.93 TSHR (0.35) MAPTTRPA1PSEN1PSEN2APH1B
SCHEMBL4842895 0.92 TRPA1 (0.39) TRPA1RORC
SCHEMBL4842573 0.92 MAPT (0.39) MAPTTRPA1RORCHPGD
SCHEMBL4841408 0.92 TRPA1 (0.36) MAPTTRPA1PTGER3HCRTR1HCRTR2
SCHEMBL4839693 0.91 MMP8 (0.41) MAPTTRPA1PTGER3RORCMMP3
SCHEMBL4842689 0.91 MMP8 (0.39) MAPTTRPA1PSEN1PSEN2APH1B
SCHEMBL4842862 0.90 TRPA1 (0.38) MAPTTRPA1PSEN1PSEN2APH1B
SCHEMBL4845148 0.88 TSHR (0.36) MAPTTRPA1PTGER3RORCPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MAPT 763/4885TRPA1 368/4885PSEN1 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.